Searchable abstracts of presentations at key conferences in endocrinology

ea0028p367 | Thyroid | SFEBES2012

Fixed drug eruption in the endocrine clinic: rare presentation of reaction to carbimazole

Pan Shwe Zin Chit , Wood Diana , Chatterjee Krishna

Background: Antithyroid drugs include thioimidazoles (carbimazole, methimazole) and propylthiouracil. Carbimazole is most commonly used in the UK. A fixed drug eruption is the drug-induced cutaneous reaction which occurs at the same site after each exposure to that agent. It is uncommon with anti-thyroid medications. Here we report this rare presentation. A 40-year-old Chinese lady who was diagnosed with Graves’ disease was initially treated with carbimazole, and then wit...

ea0015p243 | Pituitary | SFEBES2008

Pulmonary fibrosis in association with cabergoline therapy for macroprolactinoma

Annamalai Anand , Stears Anna , Wood Diana , Simpson Helen , Gurnell Mark

Background: Pleuro-pulmonary inflammatory fibrotic syndrome is a rare but recognised complication of dopamine agonist (DA) therapy in Parkinson’s disease. Here, we describe a case of asymptomatic pulmonary fibrosis, presumed secondary to DA therapy, in a patient treated with cabergoline for an invasive macroprolactinoma.Case report: A 47-year-old previously fit man was admitted as an emergency with a 3 days history of headache followed by collapse. ...

ea0065p403 | Thyroid | SFEBES2019

Iopanoic acid safely, quickly and effectively induces euthyroidism in resistant thyrotoxicosis

Samudrala Havish , Terry Isabelle , Wong Kah Fai , Wood Diana , Chatterjee Krishna , Moran Carla

Introduction: Thyrotoxicosis resistant to the usual treatment is rare, but potentially fatal. In such situations, the optimal next treatment is unclear. Iopanoic acid (IA) was historically used as an oral contrast agent; it’s capacity to treat thyrotoxicosis has been limited in recent years due to its restricted availability.Methods: Retrospective case note review of patients treated with IA for resistant thyrotoxicosis at our institution over the p...

ea0013p81 | Clinical practice/governance and case reports | SFEBES2007

Use of anti thyroid hormone receptor antibody (TRAB) in Graves’ Disease

Myint Khin Swe , Andappa Gayathridevisa Shankargall , MacFarlane Ian , Gurnell Mark , Wood Diana , Chatterjee Khris , Simpson Helen

TRAB antibody is specific for diagnosis of Grave’s disease. We have conducted an audit to on our practice on parameters which TRAB could influence.Method: TRAB (NR 0–1 IU/l) positive patients were identified from biochemistry laboratory form April 2003 to February 2004. Sixty case notes were randomly selected for reviewed. Data were analysed subsequently.Result: 46 cases (77%) were female. Mean age was 42, range 6 to 78 y...

ea0013p90 | Clinical practice/governance and case reports | SFEBES2007

Primary hyperparathyroidism in pregnancy-an increasingly common condition?

Chandran Shanthi , Wood Diana , Gurnell Mark , Chatterjee Krish , Wishart Gordon , Simpson Helen

Primary hyperparathyroidism in pregnancy is reported as being rare rare. It can be associated with significant complications. Maternal complications include symptomatic hypercalcaemia, renal calculi, hyperemesis, muscle weakness, and pre-eclampsia. Fetal complications include IUGR, low birth weight, preterm delivery, intrauterine death, neonatal tetany and fits.Patient 1 presented with asthma and was found to have primary hyperparathyroidism, corrected c...

ea0013p223 | AMEND Young Investigator's Award | SFEBES2007

Ectopic ACTH-management difficulties

Yeow Toh-Peng , Balan K , Wood Diana , Gurnell Mark , Chatterjee Krish , Simpson Helen

A 44 yr old IT systems analyst, presented in 2003 with a six month history of weight gain, diabetes and hypertension. On examination he was floridly Cushingoid. Investigations showed raised 9AM cortisol (1887 nmol/l) with failure to suppress following low and high dose dexamethasone, together with elevated 24 h urinary free cortisol (3300 nmol) and circulating ACTH (130 ng/l) levels. CT scan demonstrated a complex 11.5×9 cm lesion in the left lobe of liver and biopsy indi...

ea0065p402 | Thyroid | SFEBES2019

Rates of maternal complications from TRAb positive pregnancies are low, but strongly positive TRAb in later pregnancy is associated with adverse neonatal outcomes

Doran Isabel Huang , McFarlane James , Glasgow John Clark , Bikou Eirini , Inetinbor Emilomon , Lia Charleen , Stears Anna , Wood Diana , Gajewska-Knapik Katarzyna , Ogilvy-Stuart Amanda , Chatterjee Krishna , Moran Carla

Introduction: Graves’ disease during pregnancy may cause maternal or neonatal complications, including arrhythmia, thyroid storm, congenital anomalies and neonatal thyroid dysfunction (TD). The optimal timing and frequency of TRAb measurement in pregnant women with a history of TD, and whether fetal monitoring could be limited to those with a strongly positive TRAb, is unclear.Methods: Retrospective case note review of women with elevated TRAb (>1 i...

ea0013p247 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Sleep disorders and response to treatment in the ‘Acromegalic cardiovascular and respiratory outcomes with primary analogue therapy (ACROPAT)’ trial

Webb Alison , Pilsworth Sam , O’Toole Sam , Strey Chris , Ariyaratnam Shaumya , George Emad , Majeed Joohi , Melvin Alison , Morrish Nick , Roland Jonathan , Smith Ian , Wood Diana , Chatterjee Krishna , Simpson Helen , Shneerson John , Gurnell Mark

Respiratory disorders are a major cause of illness and impaired physical function in patients with acromegaly, contributing to 25% of all recorded deaths, with respiratory mortality 3-fold higher than in normal subjects. Sleep apnoea (SA), the phenomenon of recurrent cessation or decrease of airflow to the lungs during sleep, is the commonest reported respiratory complication. Both obstructive (OSA) and central (CSA) sleep apnoeas are known to occur, although the overall preva...